Nov 2
Current report
8-K
Director or officer change, or executive pay, Shareholder vote results
ENVB · Enveric Biosciences, Inc. · Documents
$1.52
+0.03 (+2.01%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.80M
Shares
4.48M
Volume · Nov 12
32.25K
Avg daily vol (3M)
71.41K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2023
Oct 31
Current report
8-K
Regulation FD disclosure
Oct 20
Current report
8-K
Regulation FD disclosure
Oct 18
Current report
8-K
Regulation FD disclosure
Oct 11
Current report
8-K
Regulation FD disclosure
Oct 3
Current report
8-K
Regulation FD disclosure
Sep 27
Current report
8-K
Regulation FD disclosure
Sep 20
Current report
8-K
Regulation FD disclosure
Sep 18
Proxy statement
DEF 14A
Proxy statement
Sep 18
Current report
8-K
Regulation FD disclosure
Sep 18
Annual report to holders
ARS
Annual report to holders
Sep 18
Proxy statement
DEFA14A
Proxy statement
Sep 11
Current report
8-K
Regulation FD disclosure
Sep 7
Proxy statement
PRE 14A
Proxy statement
Sep 5
Current report
8-K
Regulation FD disclosure
Sep 1
Current report
8-K
Entered into a material agreement
Aug 28
Current report
8-K
Regulation FD disclosure
Aug 28
Current report
8-K
Regulation FD disclosure
Aug 21
Current report
8-K
Regulation FD disclosure
Aug 14
Current report
8-K
Financial results
Aug 11
Quarterly report
10-Q
FY2023 Q2, ended Jun 30
Quarterly report for FY2023 Q2
Net loss $6.36M
Diluted EPS -$3.04
Jul 24
Current report
8-K
Regulation FD disclosure
Jul 17
Current report
8-K
Regulation FD disclosure
Jun 9
Jun 7
Current report
8-K
Regulation FD disclosure
Jun 6
Current report
8-K
Regulation FD disclosure
Jun 5
Current report
8-K
Regulation FD disclosure
May 30
Current report
8-K
Regulation FD disclosure
May 24
Current report
8-K
Regulation FD disclosure
May 24
Current report
8-K
Events of May 18
Ended a material agreement, Director or officer change, or executive pay
May 22
Current report
8-K
Regulation FD disclosure
May 19
Current report
8-K
Regulation FD disclosure
May 18
Current report
8-K
Regulation FD disclosure
May 15
Apr 13
Current report
8-K
Events of Apr 12
Regulation FD disclosure
Apr 10
Current report
8-K
Regulation FD disclosure
Apr 3
Current report
8-K
Financial results
Mar 31
Mar 23
Current report
8-K
Regulation FD disclosure
Mar 21
Current report
8-K
Regulation FD disclosure
Mar 14
Current report
8-K
Regulation FD disclosure
Feb 28
Current report
8-K
Events of Feb 22
Director or officer change, or executive pay
Feb 23
Current report
8-K
Regulation FD disclosure
2022
Nov 14
Oct 28
Current report
8-K
Shareholder vote results
Oct 24
Current report
8-K
Events of Oct 23
Regulation FD disclosure
Oct 6
Current report
8-K/A
Events of Sep 20
Change of auditor
Sep 23
Proxy statement
DEF 14A
Proxy statement
Sep 23
Current report
8-K
Events of Sep 20
Change of auditor
Sep 14
Current report
8-K
Regulation FD disclosure
Showing 101–150 of 243 documents
Key facts
CIK
890821
CUSIP
29405E505
13F (30d)
16 filings
12 filers
Visit website
Investor relations